Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10061)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 24, 2022 (publication date) through Jun 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2022 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | United States | 132 | 32.8% |
| 2 | Canada | 86 | 21.4% |
| 3 | China | 24 | 6% |
| 4 | Netherlands | 15 | 3.7% |
| 5 | Sweden | 15 | 3.7% |
| 6 | Brazil | 12 | 3% |
| 7 | Germany | 11 | 2.7% |
| 8 | France | 9 | 2.2% |
| 9 | Taiwan | 9 | 2.2% |
| 10 | Korea, Republic of | 8 | 2% |
| 11 | North Macedonia | 6 | 1.5% |
| 12 | Spain | 6 | 1.5% |
| 13 | India | 6 | 1.5% |
| 14 | Mexico | 5 | 1.2% |
| 15 | Morocco | 4 | 1% |
| 16 | Slovakia | 4 | 1% |
| 17 | Italy | 4 | 1% |
| 18 | Colombia | 4 | 1% |
| 19 | Australia | 3 | 0.7% |
| 20 | Portugal | 3 | 0.7% |
| 21 | Switzerland | 3 | 0.7% |
| 22 | Israel | 3 | 0.7% |
| 23 | Moldova, Republic of | 3 | 0.7% |
| 24 | Turkey | 3 | 0.7% |
| 25 | Thailand | 2 | 0.5% |
| 26 | Venezuela, Bolivarian Republic of | 2 | 0.5% |
| 27 | Poland | 2 | 0.5% |
| 28 | Argentina | 2 | 0.5% |
| 29 | Finland | 2 | 0.5% |
| 30 | Japan | 2 | 0.5% |
| 31 | Hong Kong | 2 | 0.5% |
| 32 | Ireland | 2 | 0.5% |
| 33 | Iran, Islamic Republic of | 1 | 0.2% |
| 34 | Greece | 1 | 0.2% |
| 35 | Romania | 1 | 0.2% |
| 36 | Russia | 1 | 0.2% |
| 37 | South Africa | 1 | 0.2% |
| 38 | Philippines | 1 | 0.2% |
| 39 | Nigeria | 1 | 0.2% |
| 40 | United Kingdom | 1 | 0.2% |